210 related articles for article (PubMed ID: 7946271)
1. Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin.
Blom J; Heron I; Hendley JO
APMIS; 1994 Sep; 102(9):681-9. PubMed ID: 7946271
[TBL] [Abstract][Full Text] [Related]
2. The location of surface antigens of Bordetella pertussis by immuno-electron microscopy.
Ashworth LA; Dowsett AB; Irons LI; Robinson A
Dev Biol Stand; 1985; 61():143-51. PubMed ID: 2872100
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
4. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.
Grimprel E; Bégué P; Anjak I; Njamkepo E; François P; Guiso N
Clin Diagn Lab Immunol; 1996 Jan; 3(1):93-7. PubMed ID: 8770511
[TBL] [Abstract][Full Text] [Related]
5. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
[TBL] [Abstract][Full Text] [Related]
6. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
7. Cell surface antigens of Bordetella pertussis.
Parker CD; Branes LV; Armstrong SK; Frank DW; Cole A
Dev Biol Stand; 1985; 61():123-36. PubMed ID: 2872098
[TBL] [Abstract][Full Text] [Related]
8. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
Petersen JW; Andersen P; Ibsen PH; Capiau C; Wachmann CH; Hasløv K; Heron I
Vaccine; 1993; 11(4):463-72. PubMed ID: 8470432
[TBL] [Abstract][Full Text] [Related]
9. Western blot analysis of antibody responses of young infants to pertussis infection.
Guiso N; Grimprel E; Anjak I; Bégué P
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):596-600. PubMed ID: 8223658
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
11. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].
Zakharova NS; Shmeleva EI; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Mertsalova NU; Britsina MV; Ermolova EV; Zaĭtsev EM
Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):70-2. PubMed ID: 9304336
[TBL] [Abstract][Full Text] [Related]
12. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
Cherry JD; Gornbein J; Heininger U; Stehr K
Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
[TBL] [Abstract][Full Text] [Related]
13. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
Smirnov VD; Chuprinina RP; Siundiukova RA; Maksiutov RV
Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
[TBL] [Abstract][Full Text] [Related]
14. Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine.
Ibsen PH; Petersen JW; Heron I
Vaccine; 1993; 11(3):318-22. PubMed ID: 8447160
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
Khelef N; Danve B; Quentin-Millet MJ; Guiso N
Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
[TBL] [Abstract][Full Text] [Related]
16. Protective activities in mice of monoclonal antibodies against pertussis toxin.
Sato H; Sato Y
Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
[TBL] [Abstract][Full Text] [Related]
17. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
[TBL] [Abstract][Full Text] [Related]
18. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
Storsaeter J; Hallander HO; Gustafsson L; Olin P
Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.
Isacson J; Trollfors B; Taranger J; Lagergård T
Pediatr Infect Dis J; 1995 Jun; 14(6):517-21. PubMed ID: 7667057
[TBL] [Abstract][Full Text] [Related]
20. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
